Navigation Links
Professor Suzanne Cory honored with national citation award
Date:4/3/2008

The Director of The Walter and Eliza Hall Institute, Professor Suzanne Cory, is one of the top ten Australian recipients of the 2008 Thomson Scientific Citation Awards announced at the National Press Club in Canberra.

Thomson Scientific, a US-based international information analysis company, states that The ten Australian recipientswere selected using a quantitative process that identifies the average number of citations per paper their published research has had over a period of time. This, in turn, reflects its impact and influence on the given subject and the importance attached to it by subsequent research.

As Thomson Scientific further notes, Professor Cory is one of Australias most distinguished molecular biologists, who focuses on the regulation of cell death by the bcl-2 family, with the objective of developing more effective cancer treatments.

Professor Corys nine relevant papers were cited 4,175 times in the decade to 2007, yielding an average citations per paper (CPP) of an extraordinary 463.89 the highest CPP of all the 2008 award recipients.

The Thomson Scientific awards celebrate the achievements of individual scientists and of the broader Australian scientific community. Impressively, Australia is ranked among the top ten nations in the world for influence in scientific papers, despite the nations relatively small population base. This is one of the key facts in the characterisation of Australia as a country that punches above its weight in the international science arena.

Reflecting upon the citation award, Professor Cory said, I am delighted to accept this award on behalf of the many insightful colleagues, postdoctoral fellows and students who have contributed to our BCL-2 consortium over the past twenty years. In particular, I would like to highlight the major contributions of Professor David Vaux, who made the initial breakthrough observation, and of Professor Andreas Strasser, Professor Jerry Adams, Dr David Huang and the late Dr Alan Harris, all of whom have contributed so much to our current understanding of how Bcl-2 and its relatives control the vital switch governing cell life and death. We are optimistic that this insight will contribute to the development of smarter and more effective cancer therapeutics.


'/>"/>

Contact: Brad Allan
allan@wehi.EDU.AU
61-393-452-345
Research Australia
Source:Eurekalert

Related medicine news :

1. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
2. MSU professor earns Bowditch Award for work on hypertension
3. Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology
4. Whale music captivates NJIT Professor David Rothenberg for new book, CD
5. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
6. Louisiana Tech professor is Small Times Innovator of the Year
7. Boston University School of Medicine Professor receives award from American Heart Association
8. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
9. N.J. nurses are overworked according to Rutgers College of Nursing professor
10. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
11. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: